A Study of Narmafotinib Given in Combination With Modified FOLFIRINOX in Patients With Metastatic Pancreatic Cancer
Clinical trial NCT07026279 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07026279
- Sponsor
- Amplia Therapeutics Limited
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-18
- Primary completion
- 2029-07-01
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.